PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
28732559-6	2017	In addition, a specific JAK2 inhibitor, AG490, that both attenuated TNF-alpha-induced oxidative stress, also reduced apoptosis.	alpha-cyano-(3,4-dihydroxy)-N-benzylcinnamide	40-45	tumor necrosis factor	Homo sapiens	68-77	
28901435-8	2017	In addition, the JAK2 inhibitor, AG490, decreased CXCL10 expression when administered with TNF-alpha and IFN-gamma.	alpha-cyano-(3,4-dihydroxy)-N-benzylcinnamide	33-38	tumor necrosis factor	Homo sapiens	91-100	
16354768-6	2006	Moreover, the JAK2 inhibitor alpha-cyano-(3,4-dihydroxy)-N-benzylcinnamide (AG-490) abolished PA-induced IL-1beta and IL-6 release but not TNF-alpha production, which is consistent with the notion that IL-1beta and IL-6 but not TNF-alpha contain a STAT binding element in their promoter region.	alpha-cyano-(3,4-dihydroxy)-N-benzylcinnamide	76-82	tumor necrosis factor	Homo sapiens	228-237	
19281795-0	2009	A Jak2 inhibitor, AG490, reverses lipin-1 suppression by TNF-alpha in 3T3-L1 adipocytes.	alpha-cyano-(3,4-dihydroxy)-N-benzylcinnamide	18-23	tumor necrosis factor	Homo sapiens	57-66	
19281795-6	2009	A Jak2 inhibitor, AG490, reversed the suppressive effect of TNF-alpha on both lipin-1A and -1B.	alpha-cyano-(3,4-dihydroxy)-N-benzylcinnamide	18-23	tumor necrosis factor	Homo sapiens	60-69